The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia

ConclusionsThe impact of serum uric acid reduction might have beneficial effects on CKD progression and blood pressure. However, a large prospective study is needed to determine the long-term efficacy of febuxostat therapy in CKD patients with hyperuricemia.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research